Business EconomyPosted at: Nov 8 2024 6:12PM


Granules India receives EIR from US FDA for Unit V Facility

Hyderabad, Nov 8 (UNI) Granules India Limited, a leading pharmaceutical manufacturing company, on Friday announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), in Anakapalli district of Andhra Pradesh.
The inspection was conducted by the US FDA from April 8 to April 12, 2024, the Pharma company said in a release here.
The US FDA inspection classified the facility as "No Action Indicated" (NAI), indicating compliance with current Good Manufacturing Practices (cGMP) standards and confirming that no further regulatory action is required.
This outcome reflects the facility's high standards in the production of Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for both oncology and non-oncology therapeutic areas.
During the inspection, the FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations, underscoring Granules India’s commitment to stringent quality control, regulatory compliance, and operational excellence.
"The successful completion of this US FDA inspection with zero observations and the subsequent receipt of the EIR with NAI status reflects our unwavering commitment to maintaining the highest quality standards in our manufacturing operations," said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director.
Granules India’s Unit V facility plays a pivotal role in the company’s mission to deliver high-quality and accessible pharmaceuticals globally by prioritizing regulatory compliance, operational excellence, and value delivery to stakeholders.
The company remains dedicated to producing top-quality pharmaceutical products that meet global health standards.
UNI KNR CS1811
Please log in to get detailed story.
Tags: #Granules India receives EIR from US FDA for Unit V Facility
More News

Latest US inflation report shows pullback in travel spending, increase in cost of goods

17 Jul 2025 | 7:49 AM

New York, July 17 (UNI) The muted US wholesale inflation in June has presented a better-than-expected outcome amidst President Donald Trump’s hefty tariffs on global trading partners.

see more..

Guinness owner Diageo’s CEO steps down after 2 years

17 Jul 2025 | 7:12 AM

New York, July 17 (UNI) Diageo, the world’s biggest spirits maker, announced that its CEO Debra Crew has stepped down by “mutual agreement” after being in the role for just two years.

see more..

No transactions in Hyd GPO on July 21 due to digital upgrade

16 Jul 2025 | 11:22 PM

Hyderabad, July 16 (UNI) There will be no public transactions at the Hyderabad GPO on July 21 with the Telangana Postal Circle proposing to roll out an upgraded system as part of the digital transformative system.

see more..

Kushal’s targets 300 stores in next three years

16 Jul 2025 | 9:43 PM

Bengaluru, July 16 (UNI) Kushal’s Fashion Jewellery, a leading name in India’s fashion and silver jewellery segment, has celebrated a landmark achievement with the opening of its 100th retail store, located at Nexus Koramangala Mall in Bengaluru. The milestone was marked by a grand celebration featuring Bollywood actress Nushrratt Bharuccha, who inaugurated the store.

see more..

Fino introduces “GATI” savings account to penetrate UPI transactions in Bengal

16 Jul 2025 | 9:02 PM

Kolkata, July 16 (UNI) Having made banking easy, simple and convenient, Fino Payments Bank is now focusing on making customers transact instantly right after opening a new bank account.

see more..